2026 Annual Meeting | S26 - Movement Disorders: Clinical Trials and Therapeutics

Date Tuesday 04/21/26

Time 01:00 PM - 03:00 PM CDT Add To Calendar

Location McCormick Place West | W196c

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Danielle S. Shpiner, MD, Veronica E. Santini, MD, MA, FAAN

Topic(s) Movement Disorders

CME Available 2.00 CME credits

Program Materials

Event Timeline
01:00 PM - 01:12 PM CDT	Abstract	001 - Cerebellar Network Compensation and Functional Connectivity Shifts in Parkinson’s Disease Chi-Ying (Roy) Lin, MD, FAAN
01:12 PM - 01:24 PM CDT	Abstract	002 - Remote Smartphone-based Monitoring of Parkinson’s Disease: A Real-world Multicenter Evaluation Across U.K. and U.S. Health Systems Kinan Muhammed, MBBS, PhD, MRCP
01:24 PM - 01:36 PM CDT	Abstract	003 - Continued Evaluation of Safety, Tolerability, and Clinical Outcomes in Participants with Parkinson’s Disease Throughout Three Years After Bemdaneprocel Administration Harini Sarva, MD, FAAN
01:36 PM - 01:48 PM CDT	Abstract	004 - CSM-101 is a Brain-penetrant Small Molecule Agonist of TRPML1 for Parkinson’s-related Disorders Leon Murphy, PhD
01:48 PM - 02:00 PM CDT	Abstract	005 - The Small Molecule VQ-101 Demonstrates Sustained Lysosomal Glucocerebrosidase (GCase) Activation in Idiopathic Parkinson’s Disease Maurizio Facheris, MD, MSc
02:00 PM - 02:12 PM CDT	Abstract	006 - Real-world Tolerability of Foslevodopa/Foscarbidopa Subcutaneous Infusion in Parkinson’s Disease: Discontinuation Beyond Titration Katarina Rukavina
02:12 PM - 02:24 PM CDT	Abstract	007 - Levodopa Initiation or Dose Adjustments in TEMPO-4: A 58-Week Open-label Trial of Tavapadon for Treatment of PD William Ondo, MD
02:24 PM - 02:36 PM CDT	Abstract	008 - Efficacy and Safety of Dimethyl Fumarate in Friedreich Ataxia: Primary Results From the Phase Two, Randomized, Double-blind, Placebo-controlled DMF-FA-201 Trial Francesco Sacca, MD, FAAN
02:36 PM - 02:48 PM CDT	Abstract	009 - Time to Progression to Wheelchair Comparing Troriluzole versus Untreated Natural History Cohorts in Spinocerebellar Ataxia (SCA) Sheng-Han Kuo, MD, FAAN
02:48 PM - 03:00 PM CDT	Abstract	010 - Long-Term Safety of MR-Guided Focused Ultrasound Thalamotomy in Essential Tremor and Parkinson’s Disease: Updated Evidence from Clinical Trials and Real-World Data Lindsay Knight, PhD

Faculty Disclosures
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Veronica E. Santini, MD, MA, FAAN	Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with ��ɫ��. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Michael Soileau, MD, FAAN	The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. Dr. Soileau has a non-compensated relationship as a Past President with Texas Neurological Society that is relevant to AAN interests or activities.
Angeles Sanchez Fraga, MD	Dr. Sanchez Fraga has received personal compensation for serving as an employee of Insightec Europe GmBH.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Damian R. Jenkins, MA, MB Bch, MRCP	Dr. Jenkins has nothing to disclose.
Meredith Hatcher, PA	Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
krystal Hattar	Mrs. Hattar has nothing to disclose.
Ledia Agley, PhD	Dr. Agley has nothing to disclose.
Matthew Broadus, PhD	Dr. Broadus has received personal compensation for serving as an employee of Casma Therapeutics. Dr. Broadus has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Casma Therapeutics. Dr. Broadus has stock in Casma Therapeutics.
Nicole Floro	Ms. Floro has nothing to disclose.
Andres M. Lozano, MD	Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Rebecca Heslop	Mrs. Heslop has nothing to disclose.
Giorgia Puorro	Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elma Research. Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Kristen L. Mason	Mrs. Mason has received personal compensation for serving as an employee of Harmony Biosciences.
Barbara Changizi, MD	Dr. Changizi has nothing to disclose.
Cameron Brennan	Cameron Brennan has nothing to disclose.
Alessio Sarnataro, MD	Dr. Sarnataro has nothing to disclose.
Claire Henchcliffe, MD, PhD, FAAN	Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.
joanne bromley, RN	Mrs. bromley has nothing to disclose.
Ihika Rampalli	Ms. Rampalli has nothing to disclose.
Rory Mahabir, MBA	Mr. Mahabir has nothing to disclose.
James L. Eubanks, PhD	Dr. Eubanks has received personal compensation for serving as an employee of Octave. Dr. Eubanks has stock in TG Therapeutics. Dr. Eubanks has stock in Medtronic.
Shayla Yonce	Shayla Yonce has nothing to disclose.
Helen T. Sullivan, PhD	Dr. Sullivan has a non-compensated relationship as a Advisor with MigraLearn.ai that is relevant to AAN interests or activities.
Vittoria Giordano, MD	Dr. Giordano has nothing to disclose.
Andrea De Mare, Jr., MD	Dr. De Mare has nothing to disclose.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Thamires Magalhaes, PhD	Dr. Magalhaes has nothing to disclose.
Jessica Bernard, PhD	The institution of Dr. Bernard has received research support from WoodNext Foundation. The institution of Dr. Bernard has received research support from National Institutes of Health.
Giorgia Esposito, Jr., MD	Dr. Esposito has nothing to disclose.
Amit Sokolov	Amit Sokolov has received personal compensation for serving as an employee of Insightec.
Nauman Abid, MD	Dr. Abid has received personal compensation for serving as an employee of BlueRock Therapeutics.
Leon Murphy, PhD	Mr. Murphy has or had stock in Casma Therapeutics.
Farzan S. Siddiqui, MD, PhD	Dr. Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Varian Noona Medical Advisory Board. Dr. Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Varian Medical System. The institution of Dr. Siddiqui has received research support from Varian Medical System.
Michele Potashman, PhD	Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Rachel Rich, RN	Ms. Rich has nothing to disclose.
Stephen Butterworth, MD	Dr. Butterworth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bial.
Lindsay Knight, PhD	Dr. Knight has received personal compensation for serving as an employee of Insightec.
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
Rohit Dhall, MD, FAAN	Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Alberto M. Marra, MD, PhD	Prof. Marra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MSD. Prof. Marra has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for De Grutyer.
Maurizio Facheris, MD, MSc	Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Olivia Laun	Ms. Laun has nothing to disclose.
Melissa Beiner	Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Bridget Frommel, Master of Arts	Ms. Frommel has nothing to disclose.
Victoria Wirtz	Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven.
Diego Rodriguez, Sr., MD	No disclosure on file
Michele Hu, MD	The institution of Dr. Hu has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck. The institution of Dr. Hu has received personal compensation in the range of $0-$499 for serving as a Consultant for ESCAPE Bio. The institution of Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. The institution of Dr. Hu has received research support from Parkinson's UK. The institution of Dr. Hu has received research support from Oxford BRC.
DANIEL W. BAIRD, PhD	Dr. BAIRD has received personal compensation for serving as an employee of Casma Therapeutics. Dr. BAIRD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Third Rock Ventures.
Antonella Macerollo	Antonella Macerollo has nothing to disclose.
Doreen Gruber, MD	Dr. Gruber has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Gruber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott.
Suneil Kalia	Suneil Kalia has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novonordisk. The institution of Suneil Kalia has received research support from CIHR. Suneil Kalia has received research support from MJFF. The institution of Suneil Kalia has received research support from Parkinson Canada.
Cosimo Linguetta, MD	Dr. Linguetta has nothing to disclose.
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Richard J. Ellis, MBBS	Dr. Ellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Ellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva UK. Dr. Ellis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia Pharmaceuticals.
Jorge Garcia Fortanet, Jr., PhD	Mr. Garcia Fortanet has received personal compensation for serving as an employee of DEM BioPharma. Mr. Garcia Fortanet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Casma Therapeutics. Mr. Garcia Fortanet has received intellectual property interests from a discovery or technology relating to health care.
Kenny Yu	Kenny Yu has nothing to disclose.
Kevin Hunt, PhD	Dr. Hunt has received personal compensation for serving as an employee of Vanqua Bio.
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Katie Gant	Katie Gant has received personal compensation for serving as an employee of Insightec .
Amanda y. Hulejczuk, RN, CNS	Mrs. Hulejczuk has nothing to disclose.
Daniel Ysselstein, PhD	Dr. Ysselstein has received personal compensation for serving as an employee of Vanqua Bio.
Nicola F. Findlay, RN	Mrs. Findlay has nothing to disclose.
Ingrid Koopmans	Miss Koopmans has received personal compensation for serving as an employee of Foundation The Centre for Human Drug Research.
Tracy F. Nicholson, PhD	Dr. Nicholson has received personal compensation for serving as an employee of AbbVie. Dr. Nicholson has stock in AbbVie.
Gilat Schiff	Gilat Schiff has received personal compensation for serving as an employee of Insightec.
Ian S. Pyle, PhD	Dr. Pyle has received personal compensation for serving as an employee of Insightec.
Caterina Giannini, MD, PhD	Prof. Giannini has nothing to disclose.
Chiara Pane, MD	Dr. Pane has nothing to disclose.
Philip Kremer, MD, PhD	Dr. Kremer has received personal compensation for serving as an employee of Foundation The Centre for Human Drug Research.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Timothy Lehmberg	Mr. Lehmberg has received personal compensation for serving as an employee of Casma Therapeutics . Mr. Lehmberg has received personal compensation for serving as an employee of Interdict Bio. Mr. Lehmberg has stock in Casma Therapeutics. Mr. Lehmberg has stock in Interdict Bio.
Vikrant Rai, MBBS, PhD	Dr. Rai has nothing to disclose.
Mackenzie Hagey	Mrs. Hagey has received personal compensation for serving as an employee of Vanqua Bio. Mrs. Hagey has stock in Vanqua Bio.
Alessia Bonfini Rendina, PA	Miss Bonfini Rendina has nothing to disclose.
Widad Abou Chaar, MD	Dr. Abou Chaar has nothing to disclose.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Jurrian P. van der Valk	Mr. van der Valk has received personal compensation for serving as an employee of Centre for Human Drug Research.
Harini Sarva, MD, FAAN	Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Angela Marsili	Angela Marsili has nothing to disclose.
Cyril Ferrer, PhD	Dr. Ferrer has received personal compensation for serving as an employee of Inisghtec Europe GmbH.
Vikram Khurana, MD, PhD	Dr. Khurana has received personal compensation for serving as an employee of DaCapo BrainScience. An immediate family member of Dr. Khurana has received personal compensation for serving as an employee of Arbor Therapeutics. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda Pharmaceuticals. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Khurana has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DaCapo Brainscience. Dr. Khurana has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. Dr. Khurana has stock in DaCapo Brainscience. The institution of Dr. Khurana has received research support from Sanofi. The institution of Dr. Khurana has received research support from Janssen. The institution of Dr. Khurana has received research support from Biohaven. The institution of Dr. Khurana has received research support from Tiziana Life Sciences. Dr. Khurana has received intellectual property interests from a discovery or technology relating to health care.
Kinan Muhammed, MBBS, PhD, MRCP	Dr. Muhammed has received personal compensation for serving as an employee of Kneu Health Limited. Dr. Muhammed has or had stock in Kneu Health.Dr. Muhammed has received intellectual property interests from a discovery or technology relating to health care.
Daniel N. El Kodsi, PhD	Dr. El Kodsi has nothing to disclose.
Jennifer T. Liu, MD	Dr. Liu has nothing to disclose.
Melinda Louie-Gao, PhD	Dr. Louie-Gao has received personal compensation for serving as an employee of Bluerock Therapeutics. Dr. Louie-Gao has received personal compensation for serving as an employee of Wave Life Science.
Jeremy Cosgrove, MD, MB ChB (hons)	Dr. Cosgrove has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Viviane Tabar	Viviane Tabar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. An immediate family member of Viviane Tabar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. The institution of Viviane Tabar has received research support from BlueRock. The institution of an immediate family member of Viviane Tabar has received research support from BlueRock. Viviane Tabar has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Viviane Tabar has received intellectual property interests from a discovery or technology relating to health care.
Ludovica Aliberti	No disclosure on file
Jack Beyer	Mr. Beyer has received personal compensation for serving as an employee of Vanqua Bio. Mr. Beyer has stock in Vanqua Bio.
Regina Martuscello, PhD	Dr. Martuscello has received personal compensation for serving as an employee of Insightec. Dr. Martuscello has received intellectual property interests from a discovery or technology relating to health care.
Cheri Phillips, PA	Ms. Phillips has nothing to disclose.
Georg P. Ebersbach, MD	Prof. Ebersbach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Prof. Ebersbach has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL.
Nagaraja Sarangmat	Nagaraja Sarangmat has nothing to disclose.
Andrew J. Graham, MD	Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cambridge Dementia Course.
Francis Chmiel	No disclosure on file
Augusto Grinspan, MD	Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Kathleen Skerry	Ms. Skerry has received personal compensation for serving as an employee of Apellis. Ms. Skerry has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Casma. Ms. Skerry has stock in Apellis. Ms. Skerry has stock in UnitedHealth Group.
Andrea Wong, NP	Mrs. Wong has nothing to disclose.
Mary E. Burt, RN	Mrs. Burt has nothing to disclose.
ANTONIO CITTADINI, MD	Prof. CITTADINI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK.
Martina Gramaglia, MD	Dr. Gramaglia has nothing to disclose.
teresa clarke, RN	Mrs. clarke has nothing to disclose.
Katarina Rukavina	Ms. Rukavina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint. Ms. Rukavina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Field. Ms. Rukavina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Ms. Rukavina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie GmbH. Ms. Rukavina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ever Pharma. Ms. Rukavina has received research support from European Academy of Neurology .
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Mark A. Grassman, PhD	Mr. Grassman has received personal compensation for serving as an employee of Insightec.

��ɫ����

��ɫ����

��ɫ��

��ɫ��